A nurse-led intervention for identification of drug-related problems

European Journal of Clinical Pharmacology

Volumn 64, Issue 5, 2008, Pages 451-456

  Bergqvist, Monica ^a,b   Ulfvarson, Johanna ^a,b   Andersen Karlsson, Eva ^a,b   Von Bahr, Christer ^a,b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG; WARFARIN;

ADULT; AGED; ANOREXIA; ANXIETY; ARTHRALGIA; ARTICLE; CLINICAL ASSESSMENT; CONSTIPATION; COUGHING; CREATININE CLEARANCE; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MONITORING; DRUG WITHDRAWAL; EYE DISEASE; FATIGUE; FEMALE; FOOT EDEMA; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NURSING CARE; NURSING INTERVENTION; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT; STOMACH PAIN; SWEATING; SWEDEN; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CREATININE; DRUG INTERACTIONS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING STAFF, HOSPITAL; PHARMACEUTICAL PREPARATIONS; PROCESS ASSESSMENT (HEALTH CARE);

EID: 41049114705     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0449-3     Document Type: Article

References (30)

1. von Laue NC, Schwappach DL, Koeck CM (2003) The epidemiology of preventable adverse drug events: a review of the literature. Wien Klin Wochenschr 115(12):407-415
2. Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U et al (2000) Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol 49(2):158-167
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329(7456):15-19
4. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmaco l56(2):181-186
5. Beijer HJ, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46-54
6. Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A et al (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 11(1):65-72
7. van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA (2004) Drug-related problem classification systems. Ann Pharmacother 38(5):859-867
8. ASHP Statement on Pharmaceutical care. Am J Hosp Pharm (1993) 50:1720-173
9. Dormann H, Neubert A, Criegee-Rieck M, Egger T, Radespiel-Troger M, Azaz-Livshits T et al (2004) Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med 255(6):653-663
10. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A (2006) Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 15(1):23-31
11. Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H et al (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62(12):1075-1081
12. Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A et al (2005) Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 330(7486):293
13. Ulfvarson J, Mejyr S, Bergman U (2006) Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf 16(5):532-537
14. Griffiths R, Johnson M, Piper M, Langdon R (2004) A nursing intervention for the quality use of medicines by elderly community clients. Int J Nurs Pract 10(4):166-176
15. Blue L, Lang E, McMurray JJ, Davie AP, McDonagh TA, Murdoch DR et al (2001) Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 323(7315):715-718
16. Bruggink-Andre de la Porte PW, Lok DJ, van Veldhuisen DJ, van Wijngaarden J, Cornel JH, Zuithoff NP et al (2006) Added value of a physician-and-nurse- directed heart failure clinic. Results from the DEAL-HF study. Heart. 25
17. Backstrom M, Ekman E, Mjorndal T (2007) Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol 63(6):613-618
18. Backstrom M, Mjorndal T, Dahlqvist R (2002) Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf 11(8):647-650
19. Ulfvarson J, Adami J, Ullman B, Wredling R, Reilly M, von Bahr C (2003) Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiol Drug Saf 12(7):589-593
20. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31-41
21. Läkemedelsindustriföreningen LIF (2003) Interactions. http://drugdb. Janusinfo.se/ddb/interactions/
22. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM et al (2006) Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 61(5):511-515
23. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al (2003) Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1(2):82-89
24. Nguyen JK, Fouts MM, Kotabe SE, Lo E (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4(1):36-41
25. Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Incalzi R (2005) Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 11 165(7):790-795
26. Routledge PA, O'Mahony MS, Woodhouse KW (2004) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57(2):121-126
27. Leppik IE (2006) Epilepsy in the elderly. Epilepsia 47(Suppl 1):65-70
28. van Roon EN, Flikweert S, le Comte M, Langendijk PN, Kwee-Zuiderwijk WJ, Smits P et al (2005) Clinical relevance of drug-drug interactions : a structured assessment procedure. Drug Saf 28(12):1131-1139
29. Buurma H, De Smet PA, Egberts AC (2006) Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. Drug Saf 29(8):723-732
30. Glassman PA, Belperio P, Simon B, Lanto A, Lee M (2006) Exposure to automated drug alerts over time: effects on clinicians' knowledge and perceptions. Med Care 44(3):250-256